Poor performance of hepatitis C antibody tests in hospital patients in Uganda

Journal of Medical Virology

Volumn 82, Issue 8, 2010, Pages 1371-1378

  Seremba, E ^a   Ocama, P ^a   Opio, C K ^a   Thomas, D L ^a   Yuan, H J ^b   Attar, N ^c   Lee, W M ^c  

^a MAKERERE UNIVERSITY MEDICAL SCHOOL   (Uganda)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Anti HCV; Enzyme immunoassay; Nucleic acid testing; Rapid slide test

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS ANTIBODY; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; ASSAY; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DNA DETERMINATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HOSPITALIZATION; HUMAN; IMMUNOASSAY; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RAPID STRIP ASSAY; RECOMBINANT IMMUNOBLOT ASSAY; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE; UGANDA; UNITED STATES; WEST NILE FLAVIVIRUS; BLOOD; COMPARATIVE STUDY; EVALUATION STUDY; HOSPITAL; MIDDLE AGED; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HOSPITALS; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; UGANDA; YOUNG ADULT;

HEPATITIS C VIRUS;

EID: 77956627853     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21817     Document Type: Article

References (31)

1. Allain JP. 1998. The status of hepatitis C virus screening. Transfus Med Rev 12:46-55.
2. Birungi J. 2005. Testing for hepatitis C virus infection. Clin Med Res 3:131, author reply 131-132.
3. Cadogan M, Dalgleish AG. 2008. Pathogenesis of HIV: Non-specific immune hyperactivity and its implications for vaccines. Clin Med 8:267-271.
4. Callahan JD, Constantine NT, Kataaha P, Zhang X, Hyams KC, Bansal J. 1993. Second generation hepatitis C virus assays: Performance when testing African sera. J Med Virol 41:35-38.
5. Cribier B, Rey D, Schmitt C, Lang JM, Kirn A, Stoll-Keller F. 1995. High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV. AIDS 9:1131-1136.
6. Denoyel G, van Helden J, Bauer R, Preisel-Simmons B. 2004. Performance of a new hepatitis C assay on the Bayer ADVIA Centaur Immunoassay System. Clin Lab 50:75-82. (Pubitemid 38268397)
7. Desbois D, Vaghefi P, Savary J, Dussaix E, Roque-Afonso AM. 2008. Sensitivity of a rapid immuno-chromatographic test for hepatitis C antibodies detection. J Clin Virol 41:129-133.
8. Dwyer R. 2004. The ADVIA Centaur infectious disease assays: A technical review. J Clin Virol 30:S1-S5.
9. Erhabor O, Ejele OA, Nwauche CA. 2006. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: The question of blood safety in Nigeria. Niger J Clin Pract 9:18-21.
10. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, El Khoby T, Abdel-Wahab Y, Aly Ohn ES, Anwar W, Sallam I. 2000. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355:887-891.
11. George SL, Gebhardt J, Klinzman D, Foster MB, Patrick KD, Schmidt WN, Alden B, Pfaller MA, Stapleton JT. 2002. Hepatitis C virus viremia in HIV-infected individuals with negative HCV antibody tests. J Acquir Immune Defic Syndr 31:154-162.
12. Ghany MG, Strader DB, Thomas DL, Seeff LB. 2009. Diagnosis, management, and treatment of hepatitis C: An update. Hepatology 49:1335-1374.
13. Hladik W, Kataaha P, Mermin J, Purdy M, Otekat G, Lackritz E, Alter MJ, Downing R. 2006. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors. Trop Med Int Health 11:951-954. (Pubitemid 43846456)
14. Imarengiaye CO, Enosolease ME, Iribhogbe PE, Ehigiegba AE. 2006. Risk of transfusion-transmitted hepatitis C virus in a tertiary hospital in Nigeria. Public Health 120:274-278. (Pubitemid 43286356)
15. Jeremiah ZA, Koate B, Buseri F, Emelike F. 2008. Prevalence of antibodies to hepatitis C virus in apparently healthy Port Harcourt blood donors and association with blood groups and other risk indicators. Blood Transfus 6:150-155. (Pubitemid 352031648)
16. Kamal SM, Nasser IA. 2008. Hepatitis C genotype 4: What we know and what we don't yet know. Hepatology 47:1371-1383.
17. Laperche S, Lunel F, Izopet J, Alain S, Deny P, Duverlie G, Gaudy C, Pawlotsky JM, Plantier JC, Pozzetto B, Thibault V, Tosetti F, Lefrere JJ. 2005. Comparison of hepatitis C virus NS5b and 5′ noncoding gene sequencing methods in a multicenter study. J Clin Microbiol 43:733-739. (Pubitemid 40256027)
18. Madhava V, Burgess C, Drucker E. 2002. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis 2:293-302. (Pubitemid 34464740)
19. Malan AK, Stipanovich PJ, Martins TB, Hill HR, Litwin CM. 2003. Detection of IgG and IgM to West Nile virus. Development of an immunofluorescence assay. Am J Clin Pathol 119:508-515.
20. Maylin S, Martinot-Peignoux M, Ripault MP, Moucari R, Cardoso AC, Boyer N, Giuily N, Castelnau C, Pouteau M, Asselah T, Nicolas-Chanoine MH, Marcellin P. 2009. Sustained virological response is associated with clearance of hepatitis C virus RNA and a decrease in hepatitis C virus antibody. Liver Int 29:511-517.
21. McFarlane IG, Smith HM, Johnson PJ, Bray GP, Vergani D, Williams R. 1990. Hepatitis C virus antibodies in chronic active hepatitis: Pathogenetic factor or false-positive result? Lancet 335:754-757.
22. Modi AA, Feld JJ. 2007. Viral hepatitis and HIV in Africa. AIDS Rev 9:25-39.
23. Morice Y, Roulot D, Grando V, Stirnemann J, Gault E, Jeantils V, Bentata M, Jarrousse B, Lortholary O, Pallier C, Deny P. 2001. Phylogenetic analyses confirm the high prevalence of hepatitis C virus (HCV) type 4 in the Seine-Saint-Denis district (France) and indicate seven different HCV-4 subtypes linked to two different epidemiological patterns. J Gen Virol 82:1001-1012. (Pubitemid 32454601)
24. Musana KA, Yale SH. 2005. Testing for hepatitis C Virus infection. Clin Med Res 3:132.
25. Rouet F, Chaix ML, Inwoley A, Msellati P, Viho I, Combe P, Leroy V, Dabis F, Rouzioux C. 2004. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Cote d'Ivoire: The ANRS 1236 study. J Med Virol 74:34-40. (Pubitemid 38988857)
26. Rowan BP, Smith A, Gleeson D, Hunt LP, Warnes TW. 1994. Hepatitis C virus in autoimmune liver disease in the UK: Aetiological agent or artefact? Gut 35:542-546.
27. Rustgi VK. 2007. The epidemiology of hepatitis C infection in the United States. J Gastroenterol 42:513-521. (Pubitemid 47190067)
28. Sandres-Saune K, Deny P, Pasquier C, Thibaut V, Duverlie G, Izopet J. 2003. Determining hepatitis C genotype by analyzing the sequence of the NS5b region. J Virol Methods 109:187-193. (Pubitemid 36507107)
29. Scheiblauer H, El-Nageh M, Nick S, Fields H, Prince A, Diaz S. 2006. Evaluation of the performance of 44 assays used in countries with limited resources for the detection of antibodies to hepatitis C virus. Transfusion 46:708-718.
30. Sonmez E, Ozerol IH, Senol M, Kizilkaya N, Sahin K, Ozbilge H. 1997. False-positive reaction between syphilis and hepatitis C infection. Isr J Med Sci 33:724-727. (Pubitemid 28014299)
31. Yuen MF, Hui CK, Yuen JC, Young JL, Lai CL. 2001. The accuracy of SM-HCV rapid test for the detection of antibody to hepatitis C virus. Am J Gastroenterol 96:838-841. (Pubitemid 32240741)